Changing the course of autoimmune disease

Inspired by patients. Driven to make an impact.

Latest News

March 18, 2020 • 12:00am EDT

Aurinia Announces AURORA Phase 3 Clinical Data for Voclosporin in Lupus Nephritis to be Presented at National Kidney Foundation 2020 Spring Clinical Meetings

Read Press Release View All News

March 17, 2020 • 12:00am EDT

Aurinia Pharmaceuticals Establishes U.S. Commercial Operations Center in Rockville, Maryland

Read Press Release View All News

March 16, 2020 • 12:00am EDT

Aurinia Pharmaceuticals Initiates Rolling Submission of a New Drug Application to the U.S. Food and Drug Administration for Voclosporin in the Treatment of Lupus Nephritis

Read Press Release View All News